Remdesivir, an antiviral medicine, has cured nearly all coronavirus patients after the clinical trial. A hospital in Chicago administering Remdesivir reported that the patients recovered from fever and respiratory difficulties. Remdesivir is a product of Gilead Sciences, an American biotechnology company. Following the outbreak of Coronavirus in Wuhan, several laboratory tests identified Remdesivir as the potential cure of COVID-19 disease.
All patients were administered Remdesivir daily. The antiviral made 120 patients recover within just 6 days while 3 patients took 10 days. Whereas only 2 patients died during the study.
Source: Pro Pakistani
Inflics provides it readers the information that they need in concise and short articles, making information and news more accessible to everyone.